About Kekule Life Sciences Limited
Data last updated:
Kekule Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2013PLC089588. Its GSTIN is 37AAFCK2735E1ZO (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8 Cr. It is led by directors including Sridhar Vootla (Managing Director) and Srilakshmi Kudaravalli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.9 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹4.91 Lakh (net margin -0.2%) and EBITDA of ₹2.07 Cr (EBITDA margin 9%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 1% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kekule Life Sciences. As per MCA filings, the company has open charges of ₹8.32 Cr and satisfied charges of ₹21.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kekulelife.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot 406 A H. No. 622 Road No. 18 Near Andhra Bank Jubilee H, Ills, Hyderabad, Telangana, India – 500033
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Kekule Life Sciences Limited
Kekule Life Sciences has one previous CIN (Corporate Identification Number): U74900AP2013PLC089588. The current CIN is U74900TG2013PLC089588, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TG2013PLC089588 | Current |
| U74900AP2013PLC089588 | Previous |
Associated Brands with Kekule Life Sciences Limited
Kekule Life Sciences operates one associated brand: Kekule Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract manufacturing and custom synthesis for bulk drugs and intermediates. | kekulelife.com |
Competitors & Alternatives of Kekule Life Sciences Limited
Brands and companies operating in the same space as Kekule Life Sciences Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Laurus Labs | Pharmaceutical and biotechnology company | Hyderabad, India | 2005 |
 Symbiotec | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India | 2002 |
 Beijing Biostar Technologies | APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China | 2002 |
 Sterling Pharma Solutions | Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom | 2016 |
 Provepharm Life Solutions | APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France | 1998 |
 Hikal | APIs and intermediates are produced via custom synthesis and research. | Mumbai, India | 1988 |
 Snapdragon Chemistry | Drug discovery and development service provider | Cambridge, United States | 2014 |
 SeQuent | APIs are developed and manufactured for therapeutic areas. | Bengaluru, India | 2002 |
 Jubilant Pharma | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India | 1978 |
Business Activity of Kekule Life Sciences Limited
The main business activity of Kekule Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Kekule Life Sciences Limited
Kekule Life Sciences Limited is audited by RAMASAMY KOTESWARA RAO AND CO LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMASAMY KOTESWARA RAO AND CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kekule Life Sciences Limited
Kekule Life Sciences has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Vootla | Managing Director | 20 Aug 2013 | 13 Years 1 Months | Current |
| Srilakshmi Kudaravalli | Director | 11 Oct 2019 | 6 Years 11 Months | Current |
| Apparao Vootla | Director | 20 Aug 2013 | 13 Years 1 Months | Current |
| Kudaravalli Raja Rao Also directs: Premier Klenz Private Limited, Kekule Pharma Limited, Kekule Pharmaceuticals (A.P) Limited and 3 more | Director | 20 Aug 2013 | 13 Years 1 Months | Current |
| Kudaravalli Sridhar Also directs: Kekule Pharma Limited, Alpha Energy Systems Limited | Director | 20 Aug 2013 | 13 Years 1 Months | Current |
Financials of Kekule Life Sciences Limited FY 2024 filings available
Kekule Life Sciences Limited reported revenue of ₹22.9 Cr (up 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kekule Life Sciences Limited
Revenue rose 33% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kekule Life Sciences Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.07 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kekule Life Sciences Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kekule Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kekule Life Sciences Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kekule Life Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹8.32 Cr | Open |
| 29 Mar 2023 | Others | ₹57 Lakh | Satisfied |
| 04 Jul 2022 | Others | ₹1.43 Cr | Satisfied |
| 10 Jul 2020 | Others | ₹1.27 Cr | Satisfied |
| 13 May 2020 | Others | ₹57.5 Lakh | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Kekule Life Sciences Limited
Kekule Life Sciences Limited has a workforce of 40 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kekule Life Sciences Limited
Kekule Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCK2735E1ZO | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kekule Life Sciences Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kekule Life Sciences Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kekule Life Sciences Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kekule Life Sciences Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kekule Life Sciences Limited
Frequently Asked Questions about Kekule Life Sciences Limited
Kekule Life Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 August 2013 (13+ years old) and is registered under CIN U74900TG2013PLC089588.
Kekule Life Sciences reported revenue of ₹22.9 Cr for FY 2024 (up 33% YoY).
Kekule Life Sciences has 5 current directors:
- Sridhar Vootla - Managing Director
- Srilakshmi Kudaravalli - Director
- Apparao Vootla - Director
- Kudaravalli Raja Rao - Director
- Kudaravalli Sridhar - Director
Kekule Life Sciences reported a net loss of ₹4.91 Lakh (net margin -0.2%) and EBITDA of ₹2.07 Cr (EBITDA margin 9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kekule Life Sciences is -9% over three years and -1% over five years. In the latest year (FY 2024) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kekule Life Sciences is 37AAFCK2735E1ZO, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kekule Life Sciences is U74900TG2013PLC089588. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kekule Life Sciences was incorporated on 20 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kekule Life Sciences can be reached through the website kekulelife.com. Its registered office is in Hyderabad, Telangana, India.